Pathologic Complete Responses After Chemotherapy Plus Figitumumab in Stage IV Non-Small-Cell Lung Cancer

被引：5
|
作者：
Corral, Jesus [1 ]
Lopez-Villalobos, Jose L. [1 ]
Gomez-Izquierdo, Lourdes [1 ]
Borrego, Isabel [1 ]
Paz-Ares, Luis [1 ]
机构：
[1] Hosp Univ Virgen del Rocio, Seville, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
PHASE-III TRIAL; ANTIBODY CP-751,871; GROWTH; INSULIN; COMBINATION; THERAPY;
D O I：
10.1200/JCO.2010.31.4641
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E163 / E165
页数：3
相关论文
共 50 条
  • [1] Chemotherapy of stage IIIB and IV non-small-cell lung cancer
    Cojean, I
    LeChevalier, T
    ANNALS OF ONCOLOGY, 1995, 6 : 41 - 44
  • [2] CHEMOTHERAPY FOR STAGE-IV NON-SMALL-CELL LUNG-CANCER
    BITRAN, JD
    VOKES, EE
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (06) : 1159 - 1168
  • [3] Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer
    Hill, Addie
    Gong, Jun
    Wilczynski, Sharon
    Mirza, Rizvan
    Erhunmwunsee, Loretta
    Salgia, Ravi
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (09) : 569 - +
  • [4] Adjuvant chemotherapy after complete resection in non-small-cell lung cancer
    Wada, H
    Hitomi, S
    Teramatsu, T
    Ikeda, S
    Okada, Y
    Kusakawa, M
    Soejima, R
    Teramoto, S
    Tomita, M
    Hirakawa, A
    Maeda, M
    Yamamoto, K
    Monden, Y
    Kimura, I
    Ohta, M
    Ayabe, H
    Ito, M
    Kato, H
    Genka, K
    Shimizu, N
    Tsubota, N
    Nakamoto, K
    Namikawa, S
    Matsubara, Y
    Okimoto, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1048 - 1054
  • [5] Chemoimmunotherapy for stage IV non-small-cell lung cancer
    Uprety, Dipesh
    LANCET ONCOLOGY, 2019, 20 (09): : E466 - E466
  • [6] Adjuvant chemotherapy with UFT for completely resected pathologic stage I non-small-cell lung cancer
    Paik, H
    Kim, D
    Hwang, J
    Lee, D
    LUNG CANCER, 2005, 49 : S358 - S358
  • [7] Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
    Paz-Ares, L.
    Luft, A.
    Vicente, D.
    Tafreshi, A.
    Gumus, M.
    Mazieres, J.
    Hermes, B.
    Senler, F. Cay
    Csoszi, T.
    Fulop, A.
    Rodriguez-Cid, J.
    Wilson, J.
    Sugawara, S.
    Kato, T.
    Lee, K. H.
    Cheng, Y.
    Novello, S.
    Halmos, B.
    Li, X.
    Lubiniecki, G. M.
    Piperdi, B.
    Kowalski, D. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21): : 2040 - 2051
  • [8] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
    Gandhi, L.
    Rodriguez-Abreu, D.
    Gadgeel, S.
    Esteban, E.
    Felip, E.
    De Angelis, F.
    Domine, M.
    Clingan, P.
    Hochmair, M. J.
    Powell, S. F.
    Cheng, S. Y. -S.
    Bischoff, H. G.
    Peled, N.
    Grossi, F.
    Jennens, R. R.
    Reck, M.
    Hui, R.
    Garon, E. B.
    Boyer, M.
    Rubio-Viqueira, B.
    Novello, S.
    Kurata, T.
    Gray, J. E.
    Vida, J.
    Wei, Z.
    Yang, J.
    Raftopoulos, H.
    Pietanza, M. C.
    Garassino, M. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2078 - 2092
  • [9] Challenges of Immunotherapy in Stage IV Non-Small-Cell Lung Cancer
    Stock-Martineau, Sophie
    Magner, Kate
    Jao, Kevin
    Wheatley-Price, Paul
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : 465 - +
  • [10] Palliative resection for stage IV non-small-cell lung cancer
    Swatek, Paul
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 772 - 772
12345